FIM
ANIP icon

Fernwood Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Fernwood Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55
Closed -$3.8K – 221
2024
Q1 		$3.8K Buy
+55
New +$3.32K ﹤0.01% 651

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fernwood Investment Management's ANIP Position: Q2 2024 in Review

Fernwood Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 55 shares — an estimated $3.8K sold.

Fernwood Investment Management first reported a position in ANIP in Q1 2024 and held it in 1 quarter. The position peaked at $3.8K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • Fernwood Investment Management reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 55 ANI Pharmaceuticals shares in Q2 2024, an estimated $3.8K.
  • Fernwood Investment Management first reported a position in ANI Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Fernwood Investment Management's ANI Pharmaceuticals position peaked at $3.8K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.